pharmaceuticals

Shares of Heron Therapeutics Inc (NASDAQ: HRTX) are higher after a long wait to get regulatory approval for its non-opioid pain drug. What Happened: San Diego, California-based Heron, a commercial-stage biotechnology company focused on developing treatments for unmet patient...

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was trending Tuesday afternoon possibly amid the stock making a new 52-week low. Below are the technical levels to watch on the chart. Aurinia Daily Chart Analysis: The stock is trading below both the 50-day moving average (green) as well as the 200...

EBay Inc (NASDAQ: EBAY), SunPower Corporation (NASDAQ: SPWR), Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Tupperware Brands Corporation (NYSE: TUP) are four stocks considered technically undervalued this month. Investors may seek out undervalued stocks to invest in for the...

Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a preference for risky bets at the expense of defensives such as healthcare stocks. FDA news flow of the week was mostly bordering on the negative. ACADIA...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares came under pressure Monday after the Food and Drug Administration (FDA) rejected its regulatory application seeking label expansion for its dementia drug. The Acadia Analysts: Goldman Sachs analyst Salveen Richter downgraded Acadia shares...

Biotech stocks ended the holiday-shortened week ended April 1 in the green, catalyzed by the broader market rebound and a slew of company-specific news flow. Buoyed by hopes of a U.S. government infrastructure spending program, the S&P 500 Index closed above the 4,000 level for the first...

There are challenges to value creation in the proposed separation of Bausch Health Companies Inc’s (NYSE: BHC) Bausch and Lomb (B&L) unit and RemainCo, which will be pharma-focused, according to BofA Securities. The Bausch Health Analyst: Jason Gerberry downgraded the rating for Bausch...

Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market performance. Rubius Therapeutics, Inc. (NASDAQ: RUBY) was among the biggest gainers of the week after the biopharma reported positive Phase 1/2 data for its RTX-240 in...

Biotech stocks continued to move southward in the week ended March 5, as the broader market extended its sell-off. Though light on news, the week did witness earnings releases from smaller biopharma companies, coronavirus vaccine program updates, mixed FDA rulings and clinical readouts. Morphic...

Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities passed FDA muster. NME approvals for the month included EMD Serono's Tepmetko for treating adult patients with certain types of non-small cell lung cancer,...

The U.S. Department of Justice hit Walmart Inc (NYSE: WMT) with a lawsuit on Tuesday alleging that the retailer’s shortcomings led to a rise in the nation’s opioid crisis, according to the Wall Street Journal. What Happened: In the lawsuit, the Justice Department said that Walmart...

Biotech stocks extended their weekly gains for the fourth straight week, thanks to broader market buoyancy, positive FDA decisions and vaccine news. In a widely expected decision, Moderna Inc's (NASDAQ: MRNA) coronavirus vaccine candidate was cleared for emergency use by the FDA. MacroGenics...

Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at hematology and breast cancer conferences. Positive vaccine news continued to flow. Pfizer Inc. (NYSE: PFE) and BioNTech...

Even as emergency use authorization came in late Friday for the COVID-19 vaccine from Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) announced a greater committment from the U.S. for its vaccine candidate, mRNA-1273. What Happened:...

The highly anticipated debuts of Airbnb and DoorDash are among the seven IPOs markets could see this coming week. Airbnb: Vacation rental company Airbnb is scheduled to go public on Thursday, Dec. 10 under the Nasdaq ticker symbol ABNB. The company plans to sell 51.9 million shares at a price...